Lazard Asset Management
JNCE

Lazard Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,095
Closed -$89K 2511
2021
Q3
$89K Buy
+12,095
New +$89K ﹤0.01% 1459
2021
Q2
Sell
-5,453
Closed -$56K 2124
2021
Q1
$56K Buy
+5,453
New +$56K ﹤0.01% 1391
2020
Q1
Sell
-505
Closed -$4K 1800
2019
Q4
$4K Buy
+505
New +$4K ﹤0.01% 1447